Plain-English translation of NCT06894173 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Researchers are collecting information from medical records of patients treated for two specific types of early breast cancer—HER2-positive and triple-negative breast cancer—between 2016 and 2021 across Italian hospitals. The study aims to understand what treatments doctors actually used, how well those treatments worked, and how patient outcomes were affected over time. This information will help doctors make better treatment decisions for future patients.
Doctors need to understand what treatments are most effective for these challenging breast cancer types and whether treatment approaches have changed over time. By studying real-world treatment patterns and outcomes, researchers can identify which strategies lead to the best long-term survival and recovery.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, meaning researchers will review your existing medical records from your treatment between 2016 and 2021—you won't need to visit the hospital or undergo new tests. Doctors at participating Italian cancer centers will collect information about your diagnosis, the treatments you received, how your cancer responded, and your health outcomes over time. No new treatments or medications are involved.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Italy